The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Antibody levels of Covid-19 patients decline quickly, small study shows

Mon, 22nd Jun 2020 12:54

(Sharecast News) - Levels of antibodies in people who have suffered Covid-19 reportedly falls sharply in the two to three months following their infection, a study showed, although the implications for patient immunity were unclear.
According to research published in Nature Medicine during the preceding week, declining levels of antibodies raise concerns about the length of the immune response against the new virus generated by the human body.

If correct, the research might call into question the so-called 'immunity passports' being proposed by some and support the prolonged use of public health interventions such as social distancing and isolating high-risk groups, the researchers said.

Countries like Germany had tabled the possibility that that those who have tested positive for antibodies could be allowed to move more freely than those who have not, but this research could stop such proposals in their tracks.

The research, which was conducted at Chongqing Medical University, studied 37 symptomatic Covid-19 patients and 37 asymptomatic patients, and found that 90% of those who had generated antibodies experienced sharp declines in the same over the two-to-three months after infection.

The median percentage decrease was over 70% for both types of patients.

Nonetheless, Jin Dong-Yan, a professor of virology at the University of Hong Kong, who did not participate in the study, said the results do not rule out the possibility that other parts of the immune system might offer protection, Reuters reported.

"The finding in this paper doesn't mean the sky is falling," he said, while also noting the small sample of patients that took part in the study.

Related Shares

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.